For Physicians & Medical Innovators
Custom Nutraceutical Manufacturing for Physicians & Clinicians
Built for the Medical Channel.
Olympia Biosciences™ is the only Zero-Conflict-of-Interest European CDMO purpose-built for physicians and clinicians. We engineer Evidence-Based Medicine (EBM) supplement formulas with full IP ownership transfer — turning your clinical expertise into a defensible brand asset that protects your professional reputation.
What Is a CDMO?
Contract manufacturing involves an advanced facility scaling dietary supplements from clinical formulation to final delivery systems. Olympia Biosciences™ CDMO rejects the standard private label model, offering an integrated Science First approach that ensures EBM (Evidence-Based Medicine) safety, 100% IP protection, and transforms production into a hard technological asset for your clinic or enterprise.
The Market Shift
Why physicians with clinical authority demand a true CDMO — not a private label factory.
The global nutraceutical market has reached a point where physicians can no longer ignore the quality gap.
An increasing number of medical professionals — from integrative medicine practitioners to oncologists and endocrinologists — are responding by creating their own evidence-based supplement lines.
The challenge is finding a manufacturer that operates at the clinical standard physicians demand. Most supplement factories are built for mass-market private label production — they do not understand the reputational risk a doctor faces.
Olympia Biosciences™ exists specifically for the medical channel: an end-to-end CDMO providing pharmaceutical-level analytics, AI-verified safety, and complete regulatory shielding. You focus on the patients. We handle the factory.
Quality Architecture
What makes it "Medical-Grade"
"Medical grade" is not marketing language at Olympia Biosciences™ — it describes our actual production protocols. Every custom supplement formulation undergoes the same rigor applied in pharmaceutical manufacturing.
HPLC/GC-MS Verification
Every batch is analytically verified using high-performance liquid chromatography and gas chromatography-mass spectrometry. We confirm the exact active compound content — not just what the label claims.
AI-Verified Interaction Screening
After our R&D team designs your formula, our proprietary AI model screens every formulation for ingredient interactions and the cocktail effect. An additional safety layer that no other CDMO provides.
Featured in Forbes ›Clinical Dosage Precision
We formulate at clinically validated dosages based on published research — not the "minimum effective dose" used by mass-market manufacturers to superficially cut costs.
Full IP Ownership Transfer
Every formula is built from scratch for your project. Upon completion, full intellectual property rights transfer to you. Your formulation is yours — permanently and exclusively.
Turnkey Execution
How to launch a clinical brand in 2026
Launching a physician-formulated supplement brand does not require building a factory or hiring a team of food scientists. As an end-to-end CDMO partner, Olympia Biosciences™ handles the entire process:
Clinical Consultation
Share your therapeutic concept. Our R&D team conducts a feasibility audit, evaluating ingredient availability, regulatory pathways, and formulation complexity.
Custom Formulation & AI
We develop your formula from scratch, selecting the optimal delivery system. Every formula undergoes AI-powered safety screening.
GMP Production
Manufactured in our ISO 22000 / ISO 9001 certified facility under pharmaceutical-grade protocols. Starting at 5,000 units.
Analytical Verification
HPLC and GC-MS testing confirms active compound content. You receive a comprehensive Certificate of Analysis (CoA) for every batch.
Regulatory Shielding
We prepare EFSA-compliant labeling, handle notification processes, and manage export documentation. The regulatory paperwork never lands on your desk.
IP Transfer & Launch
Full formula ownership transfers to you. Your medical brand launches with proprietary, defensible intellectual property.
Financial Architecture
Manufacturing Costs:
CAPEX vs. OPEX
Building your own production facility requires massive capital expenditure (CAPEX): GMP-compliant clean rooms, analytical equipment, regulatory certifications, and specialized personnel. For most medical practices, this is neither practical nor financially rational.
Working with a nutraceutical CDMO like Olympia Biosciences™ converts this into operational expenditure (OPEX). You pay for formulation development and per-unit production — without the infrastructure burden. This model allows physicians to launch premium, medical-grade supplement brands with manageable investment and highly predictable unit economics.
The CAPEX Trap
Millions frozen in infrastructure, clean rooms, and compliance audits before a single bottle is sold. Significant operational and regulatory risk.
The CDMO OPEX Advantage
Pay only for R&D and finished, validated products. Zero infrastructure risk. Full regulatory compliance and rapid scalability built-in.
R&D Discovery Investment
~€15,000
Pilot scale-up starting investment for a 5,000-unit proprietary brand
At Olympia Biosciences™ CDMO, we do not compete on commodity pricing; we compete on clinical efficacy and supply chain security. R&D discovery and pilot scale-up investments are tailored to formulation complexity, typically starting around €15,000 to ensure batch-to-batch stability for initial runs of 5,000 units. For enterprise scale-up exceeding 500,000 units, we engineer highly optimized, industrialized unit economics.
Our Partners
Medical Specialties We Serve
We also partner with healthcare-focused venture capital funds seeking to build portfolio supplement brands with genuine clinical differentiation.
Our IP Pledge
We do not own consumer brands.
We never compete with our clients.
Every formula engineered at Olympia Biosciences™ is built from scratch and transferred to you with full intellectual property ownership. Zero conflict of interest — guaranteed by ISO 27001 cybersecurity and ironclad NDAs.
Ready to Launch Your Clinical Brand?
From concept to market-ready product — physician formulated supplement manufacturing with full IP ownership. Schedule a confidential consultation with our scientific board.
Frequently Asked Questions
What makes Olympia Biosciences™ different from standard supplement manufacturers?
What is the minimum order quantity for physician-branded supplements?
What regulatory support does Olympia Biosciences™ provide for physician supplement brands?
Can physicians use Olympia Biosciences™ to create EBM (Evidence-Based Medicine) supplement formulas?
What is the process for a physician to launch their own supplement brand with Olympia Biosciences™?
Does Olympia Biosciences™ manufacture supplements for functional medicine practices?
Strictly B2B / Educational R&D Disclaimer
The pharmacokinetic data, clinical references, and scientific literature referenced on this page are provided strictly for B2B formulation, educational, and R&D purposes for medical professionals, pharmacologists, and brand developers. Olympia Biosciences™ operates solely as a Contract Development and Manufacturing Organization (CDMO) and does not manufacture, market, or sell consumer end-products.
Global Regulatory & No Health Claims. Nothing on this page constitutes a health claim, medical claim, or disease-risk-reduction claim within the meaning of EU Regulation (EC) No 1924/2006, the U.S. Dietary Supplement Health and Education Act (DSHEA), or other global regulatory frameworks. These statements and raw data have not been evaluated by the Food and Drug Administration (FDA), European Food Safety Authority (EFSA), or Therapeutic Goods Administration (TGA). The raw active pharmaceutical ingredients (APIs) and formulations discussed are not intended to diagnose, treat, cure, or prevent any disease.
Client Responsibility. The B2B client who commissions a formulation from Olympia Biosciences™ bears full and sole responsibility for all regulatory compliance, health claim authorization (including EFSA Article 13/14 claim dossiers and U.S. FDA notifications), labeling, and marketing of their finished product in their target market(s). Olympia Biosciences™ provides manufacturing, formulation, and analytical services only.